JonathanKayMD

PubMed

• 3 citations
  Healing of erosions in rheumatoid arthritis remains elusive: results with 24 months of the anabolic agent teriparatide
  Jeffrey Duryea, Ellen M. Gravallese, J R Wortman, Chang Xu, Bing Lu, Jonathan Kay, Daniel H. Solomon> ;Scandinavian Journal of Rheumatology. 2021 Jan 2
• 1 citations
  Physical Activity and Attitudes Toward Exercise in People With Axial and Peripheral Spondyloarthritis.
  Shao-Hsien Liu, Divya Shridharmurthy, Kate L. Lapane, Catherine Dubé, Ellen M. Gravallese, Jonathan Kay> ;The Journal of Rheumatology. 2021 Apr 1
• 17 citations
  Primary care physician perspectives on barriers to diagnosing axial Spondyloarthritis: a qualitative study.
  Kate L. Lapane, S. Khan, Divya Shridharmurthy, Ariel L. Beccia, Catherine Dubé, Esther Yi, Jonathan Kay, Shao-Hsien Liu> ;BMC Family Practice. 2020 Sep 29
• 14 citations
  Interchangeability of Biosimilars: What Level of Clinical Evidence is Needed to Support the Interchangeability Designation in the United States?
  Daniel F. Alvarez, Gertjan Wolbink, Carol Cronenberger, John Orazem, Jonathan Kay> ;Biodrugs. 2020 Sep 29
• 12 citations
  Examining Treatment Decision-Making Among Patients With Axial Spondyloarthritis: Insights From a Conjoint Analysis Survey.
  Woojin Joo, Christopher V. Almario, Mariko L. Ishimori, Yujin Park, Benjamin Noah, Lianne S. Gensler, R. Swamy Venuturupalli, Jonathan Kay, Michael H. Weisman, Brennan...> ;ACR Open Rheumatology. 2020 Jul 1
• 1 citations
  Impact of immunogenicity on efficacy and tolerability of tumour necrosis factor inhibitors: pooled analysis of biosimilar studies in rheumatoid arthritis.
  Paul Emery, C-H Suh, Michael E. Weinblatt, Josef S Smolen, E.C. Keystone, Mark C. Genovese, Jiri Vencovsky, Jonathan Kay, E. Hong, Y. Baek, Jeehoon Ghil> ;Scandinavian Journal of Rheumatology. 2020 May 29
• 12 citations
  Biosimilar Uptake in Academic and Veterans Health Administration Settings: Influence of Institutional Incentives.
  Joshua F. Baker, Charles E. Leonard, Vincent Lo Re, Michael H. Weisman, Michael D. George, Jonathan Kay> ;Arthritis & Rheumatology. 2020 May 5
• 27 citations
  Unmet need in rheumatology: reports from the Targeted Therapies meeting 2019.
  Kevin L Winthrop, Michael E Weinblatt, Joan Bathon, Gerd R Burmester, Philip J Mease, Leslie Crofford, Vivian Bykerk, Maxime Dougados, James Todd Rosenbaum, Xavier Mar...> ;Annals of the Rheumatic Diseases. 2020 Jan 1
• 7 citations
  Will savings from biosimilars offset increased costs related to dose escalation? A comparison of infliximab and golimumab for rheumatoid arthritis
  Jeffrey R. Curtis, Fenglong Xie, Jonathan Kay, Joel Kallich> ;Arthritis Research & Therapy. 2019 Dec 12
• 14 citations
  The “Treat-to-Target” Approach to Rheumatoid Arthritis
  Karen Salomon-Escoto, Jonathan Kay> ;Rheumatic Diseases Clinics of North America. 2019 Aug 9
• 13 citations
  Unmet need in rheumatology: reports from the Targeted Therapies meeting 2018.
  Kevin L Winthrop, Michael E Weinblatt, Mary K Crow, Gerd R Burmester, Philip J Mease, Alexander K So, Vivian Bykerk, Ronald F Van Vollenhoven, Maxime Dougados, Jonatha...> ;Annals of the Rheumatic Diseases. 2019 Jul 1
• 59 citations
  A Fifty-Two-Week, Randomized, Placebo-Controlled Trial of Certolizumab Pegol in Nonradiographic Axial Spondyloarthritis
  Atul Deodhar, Lianne S. Gensler, Jonathan Kay, Walter P. Maksymowych, Nigil Haroon, Robert Landewé, Martin Rudwaleit, Stephen Hall, Lars Bauer, Bengt Hoepken, Natasha ...> ;Arthritis & Rheumatology. 2019 Jul 1
• 1 citations
  A 'wind of change' to biosimilars: The NOR-SWITCH trial and its extension
  Jonathan Kay> ;Journal of Internal Medicine. 2019 Jun 1
• 20 citations
  Patient Concerns and Perceptions Regarding Biologic Therapies in Ankylosing Spondylitis: Insights From a Large-Scale Survey of Social Media Platforms
  Eldin Dzubur, Carine Khalil, Christopher V. Almario, Benjamin Noah, Deeba Minhas, Mariko L. Ishimori, Corey W. Arnold, Yujin Park, Jonathan Kay, Michael H. Weisman, Br...> ;Arthritis Care & Research. 2019 Feb 1
• 8 citations
  Immunohistochemical biomarker validation in highly selective needle biopsy microarrays derived from mpMRI-characterized prostates.
  Jonathan Olivier, Vasilis Stavrinides, Jonathan Kay, Alex Freeman, Hayley Pye, Zeba Ahmed, Lina M. Carmona Echeverria, Susan Heavey, Lucy A.M. Simmons, Abi Kanthabalan...> ;The Prostate. 2018 Aug 2
• 145 citations
  Sequencing of prostate cancers identifies new cancer genes, routes of progression and drug targets
  David C. Wedge, Gunes Gundem, Thomas J. Mitchell, Dan J. Woodcock, Inigo Martincorena, Mohammed J. R. Ghori, Jorge Zamora, Adam Butler, Hayley C. Whitaker, Zsofia Kote...> ;Nature Genetics. 2018 Apr 16
• 31 citations
  The Science Behind Biosimilars: Entering a New Era of Biologic Therapy.
  S. Louis Bridges, Douglas W. White, Angus B Worthing, Ellen M. Gravallese, James R. O'Dell, Kamala Nola, Jonathan Kay, Stanley Cohen> ;Arthritis & Rheumatology. 2018 Mar 1
• 138 citations
  Consensus-based recommendations for the use of biosimilars to treat rheumatological diseases
  Jonathan Kay, Monika Schoels, Thomas Dörner, Paul Emery, Tore K Kvien, Josef S Smolen, Ferdinand C. Breedveld> ;Annals of the Rheumatic Diseases. 2018 Feb 1
• 2 citations
  Anti-cyclic citrullinated peptide antibodies, other common autoantibodies, and smoking as risk factors for lymphoma in patients with rheumatoid arthritis.
  Eva Baecklund, Carin Backlin, Johan Rönnelid, René E. M. Toes, Twj Huizinga, Erik Åhlin, Johan Askling, F H Hochberg, L. Klareskog, Jonathan Kay, Karin E. Smedby> ;Scandinavian Journal of Rheumatology. 2018 Jan 16
• 1 citations
  Transthoracic echocardiography is adequate for intraprocedural guidance of transcatheter aortic valve implantation
  Renuka Jain, Daniel P. O'Hair, Tanvir Bajwa, Denise Ignatowski, Daniel R Harland, Amanda Kirby, Tracy Hammonds, Suhail Allaqaband, Jonathan Kay, Bijoy K. Khandheria> ;Echo Research and Practice. 2017 Dec 1
• 27 citations
  Effects of Teriparatide on Joint Erosions in Rheumatoid Arthritis: A Randomized Controlled Trial.
  Daniel H. Solomon, Jonathan Kay, Jeffrey Duryea, Bing Lu, Marcy B. Bolster, Robert A. Yood, Roger Han, S. Ball, C. Coleman, E. Lo, Alyssa Wohlfahrt, M. Sury, M. Yin, Z...> ;Arthritis & Rheumatology. 2017 Sep 1
• 8 citations
  Pharmacotherapy: Biosimilar switching — “To set a form upon desired change”
  Jonathan Kay, Kevin L. Winthrop> ;Nature Reviews. Rheumatology. 2017 Jun 1
• 57 citations
  Tocilizumab combination therapy or monotherapy or methotrexate monotherapy in methotrexate-naive patients with early rheumatoid arthritis: 2-year clinical and radiogra...
  Gerd R Burmester, William F. C. Rigby, Ronald F van Vollenhoven, Jonathan Kay, Andrea Rubbert-Roth, Ricardo Blanco, AK Kadva, Sophie Dimonaco> ;Annals of the Rheumatic Diseases. 2017 Jul 1
• 18 citations
  Biosimilars: implications for rheumatoid arthritis therapy.
  Stanley Cohen, Jonathan Kay> ;Current Opinion in Rheumatology. 2017 May 1
• 85 citations
  Treat-to-target (T2T) recommendations for gout
  Uta Kiltz, Josef S Smolen, Thomas Bardin, A Cohen Solal, Nicola Dalbeth, Michael Doherty, B Engel, C Flader, Jonathan Kay, M Matsuoka, Fernando Perez-Ruiz, G da Rocha ...> ;Annals of the Rheumatic Diseases. 2017 Apr 1
• Join now to see all